about
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementRole of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 miceHypoxia-inducible factors as molecular targets for liver diseasesDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Chemical imaging on liver steatosis using synchrotron infrared and ToF-SIMS microspectroscopiesNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDDetecting hepatic steatosis using ultrasound-induced thermal strain imaging: an ex vivo animal study.CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitisShear wave velocity is a useful marker for managing nonalcoholic steatohepatitisCombined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?Nonalcoholic fatty liver disease: Diagnostic biomarkers.Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietThe Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver DiseaseMarkedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan.Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.Diet-induced obesity modulates epigenetic responses to ionizing radiation in mice.Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.Complement alternative pathway activation in human nonalcoholic steatohepatitis.Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasoundPro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.Curcumin limits the fibrogenic evolution of experimental steatohepatitis.Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.Resistance to diet-induced obesity in mice with synthetic glyoxylate shuntSystematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial.New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in JapanInflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.Diagnosis and evaluation of nonalcoholic fatty liver disease.The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver diseaseSerum autotaxin is independently associated with hepatic steatosis in women with severe obesity.Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.Coffee consumption and NAFLD: a community based study on 1223 subjects.Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension
P2860
Q24649618-5A6A215E-A5B8-485B-8FDA-8C1F1731D7D0Q24657152-8161E6BD-80A8-4AB0-990F-4C791349829CQ26752304-1B82B66E-2BBF-4C86-9858-178A394BB068Q26998471-7D82558C-CC02-40AB-AECF-50FCF556466AQ27008277-976D4580-F69B-4609-A7AE-7363385D2FB6Q28476303-02473629-E8B1-4A2A-8900-44C98CEA7B04Q28488938-8FD3F123-26CA-417C-BC10-3B38F7130AD5Q30418371-13B7ABEE-E822-46E5-8924-F4E9235DBC5AQ30434253-135159CB-2680-432F-A545-F7FF87B0F5A0Q30480973-18093586-F251-4768-AABB-CDCC75F7EE92Q33363300-FA96BFB9-A69E-4B05-A760-50A43C27EBACQ33397694-58913AA7-2B8D-4671-9D3A-C83936454D89Q33514542-B90AF7B4-37E1-43D4-99E8-242D682A5FD0Q33563333-F2D0839F-67DC-45E9-B1FA-324B667C5B70Q33660027-125A75B2-63A8-4C7E-A8A4-26BC2A8F6A81Q33706254-C8C87687-CB2C-4012-9128-16F82CBB736EQ33804734-70F22D84-9C59-4439-BE37-1C238CD3933AQ34003370-66E3C74B-B918-4372-8070-FF222CF68DECQ34015290-A5726A3C-DECD-4A02-B749-E76BAFB74970Q34056163-6CD914A7-6169-468A-BF9B-14604248FE09Q34110597-F94BD537-6BA2-4654-B45D-CAC673CFAAFCQ34207845-4848EFC7-CD45-4046-A7BA-3D1CF2FDAC1CQ34311151-F5E29B37-C046-4966-A986-A31E4A3CF463Q34317685-118E6A87-27B6-4E8A-AEDE-0BDDEE0B0653Q34331647-67EF2D57-4269-41BC-8672-BC84DD737A4BQ34406470-E714BDBD-7DD9-48E2-AE78-E3345717E14BQ34613675-0EFD2B62-699A-4835-9992-D0C81C9B8E24Q34626474-F0842F6D-B0AC-4A03-A4E7-FE915B9B7665Q34769732-C44E492B-DD1E-4218-8BD8-BD041D348942Q34778767-376AC3B6-327E-4460-B789-EFFBDEA904DDQ34830398-1124C89A-432F-44B0-8DF5-AD8E6C19024AQ35161711-FCE6B5A4-BFF0-447A-BE89-95EAA8CAA161Q35289022-1F347BAC-E8AE-401A-B1DD-DA83B81BBD09Q35402168-2997B752-4BB8-4DA9-92C3-F1BC401F96D0Q35495753-B07E7C0E-3E90-45C9-9A8D-D07CB4F1DF52Q35513535-116E91C7-5259-4746-8B3A-B40036FCE4E0Q35553828-59857E47-1809-4FF0-82A0-53F34FE422B2Q35661889-67F2C1CE-932C-4C80-8206-261B30C312ECQ35831047-7ACC9668-D75A-4BAC-B5BC-3C5E12E5E00DQ35857858-2442B278-5E13-4B36-87C0-E0EF17917BB7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis and therapy of nonalcoholic steatohepatitis.
@en
Diagnosis and therapy of nonalcoholic steatohepatitis.
@nl
type
label
Diagnosis and therapy of nonalcoholic steatohepatitis.
@en
Diagnosis and therapy of nonalcoholic steatohepatitis.
@nl
prefLabel
Diagnosis and therapy of nonalcoholic steatohepatitis.
@en
Diagnosis and therapy of nonalcoholic steatohepatitis.
@nl
P1433
P1476
Diagnosis and therapy of nonalcoholic steatohepatitis.
@en
P2093
Dawn M Torres
Stephen A Harrison
P304
P356
10.1053/J.GASTRO.2008.02.077
P407
P577
2008-05-01T00:00:00Z